ESM
1,3,5(10)-ESTRATRIEN-2,3,17-BETA-TRIOL 2-METHYL ETHER
Find entries where: ESM
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | 1,3,5(10)-ESTRATRIEN-2,3,17-BETA-TRIOL 2-METHYL ETHER |
Synonyms | 2-METHOXYESTRADIOL |
Identifiers | (8R,9S,13S,14S,17S)-2-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol |
Formula | C19 H26 O3 |
Molecular Weight | 302.41 |
Type | NON-POLYMER |
Isomeric SMILES | C[C@]12CC[C@@H]3c4cc(c(cc4CC[C@H]3[C@@H]1CC[C@@H]2O)O)OC |
InChI | InChI=1S/C19H26O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,18,20-21H,3-8H2,1-2H3/t12-,13+,15-,18-,19-/m0/s1 |
InChIKey | CQOQDQWUFQDJMK-SSTWWWIQSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 48 |
Chiral Atom Count | 5 |
Bond Count | 51 |
Aromatic Bond Count | 6 |
Drug Info: DrugBank
DrugBank ID | DB02342 |
---|---|
Name | 2-Methoxyestradiol |
Groups | investigational |
Description | 2-Methoxyestradiol (2ME2) is a drug that prevents the formation of new blood vessels that tumors need in order to grow (angiogenesis). It has undergone Phase 1 clinical trials against breast cancers and preclinical studies suggest that 2ME2 could also be effective against inflammatory diseases such as rheumatoid arthritis. |
Synonyms |
|
Indication | For the treatment of breast cancer and inflammatory diseases such as rheumatoid arthritis. |
Categories |
|
CAS number | 362-07-2 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Catechol O-methyltransferase | MPEAPPLLLAAVLLGLVLLVVLLLLLRHWGWGLCLIGWNEFILQPIHNLL... | unknown | |
Cytochrome P450 1A1 | MLFPISMSATEFLLASVIFCLVFWVIRASRPQVPKGLKNPPGPWGWPLIG... | unknown | |
Cytochrome P450 1B1 | MGTSLSPNDPWPLNPLSIQQTTLLLLLSVLATVHVGQRLLRQRRRQLRSA... | unknown | |
Cytochrome P450 19A1 | MVLEMLNPIHYNITSIVPEAMPAATMPVLLLTGLFLLVWNYEGTSSIPGP... | unknown | |
Hypoxia-inducible factor 1-alpha | MEGAGGANDKKKISSERRKEKSRDAARSRRSKESEVFYELAHQLPLPHNV... | unknown | |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
CCDC/CSD | SANCOC |
PubChem | 66414 |
ChEBI | CHEBI:28955 |
ChEMBL | CHEMBL299613 |
Pharos | CHEMBL299613 |